Nitric oxide | INOmax® (INO Therapeutics, Inc.) | In conjunction with ventilatory support and other appropriate agents, in the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it i | Drug Information Portal
|